Clinical Trial Update: Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing sirolimus, everolimus, and mycophenolate in kidney transplant recipients; results completed with posted results in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• Everolimus (everolimus)
• MycoPhenolate (mycophenolate mofetil)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Hospital do Rim e Hipertensão | Conditions: Kidney Transplant Infection | Phase 4 | Status: COMPLETED | Results posted: 2023-04-24